Wockhardt pharma
Wockhardt Q1 net loss at Rs 16 crore; total income at Rs 769 crore
Wockhardt shareholders reject proposal to raise Rs 1,600 crore from promotor
Wockhardt initiates phase-III clinical study of new antibiotic candidate
/newsdrum-in/media/agency_attachments/2025/01/29/2025-01-29t072616888z-nd_logo_white-200-niraj-sharma.jpg)
/newsdrum-in/media/media_files/MxiOumI8DazzlGgzLykO.jpg)
/newsdrum-in/media/media_files/6iFnMKWCJbZ9gXA3raVU.jpg)
/newsdrum-in/media/post_banners/HCwRvK2Ll1hyREefV1tS.jpg)
